New Test To Predict Alzheimer’s 20 Years Early

According to New Atlas, physicists from the Australian National University (ANU) have collaborated in groundbreaking research that combines nanotechnology, artificial intelligence, and molecular biology to create a great method for identifying protein markers associated with Alzheimer’s disease in blood. These markers have become the early indicators of early neurodegeneration and the early detection of Alzheimer’s and have become our most potent weapon for effectively intervening in its progression. This disease has become one of the most scary brain disorders anyone can get, but it is mostly associated with old age. As we age, our brain also gets old, and catching these diseases becomes easier.

AI is utilized in this research

While there is no cure for this debilitating disease, gaining a 20-year head start in identifying symptoms can potentially have a great early start, altering the course of health outcomes for affected individuals. The Australian National University (ANU) physicists have engineered an ultra-thin silicon chip equipped with nanometer-sized openings that can scrutinize the proteins individually. It is all done with the assistance of an advanced AI algorithm. A small amount of the patient’s blood is placed onto the silicon chip and inserted into a compact device. This portable device then uses the AI algorithm to check the signatures corresponding to the proteins that exhibit early signs of Alzheimer’s disease. It’s important to know that while there is presently no known cure for Alzheimer’s, the significance of this research work cannot be ignored.

Alzheimer’s is a common neurodisorder

Shankar Dutt, a researcher at ANU, highlights how, by this technology, we get the ability to check an individual’s risk of developing Alzheimer’s disease two decades before a diagnosis and how this could greatly impact patients’ health prospects. Alzheimer’s is a neurodegenerative disease that gradually slowly affects individuals and attacks their cognitive abilities and independence. This not only affect the patient but also the family of the patient. The lack of a cure has made early detection a very important thing, as certain interventions at the earliest stages of the disease can help slow its progression and improve the quality of life for those suffering.